This inventor holds 15 USPTO granted patents. Top assignees: National Research Council of Canada, The Brigham and Women's Hospital, Inc., Canadian Patents & Development Ltd.. Active years: 1982-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ottawa, CA (1982)
- Gloucester, CA (1988 - 2003)
Company Filing History:



Years Active: 1982-2003
Title: The Innovations of Harold J. Jennings
Introduction
Harold J. Jennings is an influential inventor based in Gloucester, California, renowned for his significant contributions to the field of vaccine development. With a remarkable portfolio of 15 patents, Jennings has played a key role in advancing medical science, particularly in the realm of meningococcal vaccines.
Latest Patents
One of Jennings' notable inventions includes advancements in meningococcal polysaccharide conjugate vaccines. This invention focuses on chemically-modified group B polysaccharides and demonstrates innovative vaccine compositions where modified polysaccharides are conjugated to protein carriers. Furthermore, Jennings has developed novel group B meningococcal unsaturated N-acyl derivative polysaccharides and their corresponding conjugates. His dedication to this research has led to pharmaceutical compositions that incorporate these conjugate molecules, which are integral for vaccine development aimed at preventing meningococcal infections. Another significant patent involves antibodies to meningococcal polysaccharide conjugate vaccines, further showcasing his expertise in this vital area of health.
Career Highlights
Throughout his career, Jennings has been associated with prestigious organizations that paved the way for his advancements in vaccine technology. Notable institutions include the National Research Council of Canada and Brigham and Women's Hospital, Inc. His experience in these research environments has significantly contributed to his innovative capabilities and understanding of vaccine development.
Collaborations
Jennings has collaborated with distinguished colleagues, including Francis Michon and Dennis L. Kasper. These professional relationships have allowed for a robust exchange of ideas and research, resulting in breakthroughs and refinements in vaccine technology.
Conclusion
Harold J. Jennings' work exemplifies the spirit of innovation in medical science. With his extensive patent portfolio and collaborative efforts, he has made substantial contributions to the development of vaccines that play a crucial role in public health. His legacy continues to inspire future generations of inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile